HAVEN MD: Clinical Intelligence in the Palm of Your Hand. Zero Hallucination.
EMPHOS Group · April 21, 2026 · 5 min read
The AI industry has been moving into medicine for years. The results have been mixed in ways that matter enormously when the stakes are human health.
The core problem is not that AI systems are bad at medicine. It is that the AI systems currently being deployed in clinical contexts are architecturally incapable of distinguishing between what they know and what they are producing because it sounds plausible. A language model that invents a drug name, fabricates a contraindication, or hallucinates a dosage does not know it is doing so. It generates a confident, fluent, medically-formatted answer because confident, fluent, medically-formatted answers are what its training data rewarded.
In most domains, that is a problem. In medicine, it is a patient death.
HAVEN MD is built on a different architecture. One that cannot hallucinate. Not because it has been trained carefully, aligned thoroughly, or prompted to be cautious. Because the architecture makes fabrication structurally impossible.
What makes zero hallucination a guarantee, not a claim
HAVEN MD runs Heinrich AI — Frequency Addressed Intelligence. Heinrich stores knowledge as physics: every concept has a precise frequency address, every relationship is encoded as a verifiable property of the knowledge field. To answer a query, Heinrich navigates to an address and reads what is there. If the address does not exist, or if the relationships are too weak to support a confident answer, Heinrich reports that gap explicitly.
There is no pathway in Heinrich's architecture for producing an answer it does not have. Zero amplitude is the output. The gap is reported. The clinician is not told something that is not true.
In a drug interaction check, this means: Heinrich traces the molecular relationship through its field of 84,000 protein nodes and 111,000 gene nodes. If the path exists and is strong, it returns the interaction with a confidence level. If the path does not exist in the field, it says so — which means either the interaction is not present or the field has not yet encoded it. Both outcomes are honest. Neither is dangerous.
Healthcare is the domain where this distinction matters most. HAVEN MD does not attempt to be the most capable clinical AI. It attempts to be the only one you can trust completely.
The clinical knowledge field on the device
HAVEN MD carries the deepest biological knowledge field of any on-device AI clinical system in existence. Pharmacology covering thousands of approved drugs with interaction, dosing, and contraindication relationships. Full body anatomy. Physiology normal ranges by age, sex, and condition. Disease concepts mapped to ICD-11 relationships. Genomics, clinical procedures, symptom relationship chains, and nutrition-drug interaction pathways — all resident on the device, all queryable in two to twenty-one milliseconds, all available with no network connection.
This is the knowledge that answers the questions a paramedic needs answered at an accident scene when there is no cell signal. The differential that narrows a complex presentation in a rural clinic where the nearest specialist is four hours away. The drug interaction check that a nurse needs at three in the morning when the on-call pharmacist is unavailable.
HAVEN MD gives all three of those clinicians the same depth of clinical knowledge as a major urban hospital. In a 200-gram device, in their hand, offline, instantly.
The thermal problem that AI has not solved anywhere else
Conventional AI inference chips draw one to five watts continuously. A handheld clinical device running at those power levels generates enough heat to be uncomfortable to hold for an extended clinical session. For a device intended to be carried and used continuously through a clinical shift, that is not an acceptable design constraint.
Heinrich's inference layer in HAVEN MD draws approximately three milliwatts. The total device draw — display active, sensors running, BLE connected — peaks at around 830 milliwatts with the screen fully bright. Screen off, in query mode, the device draws 35 milliwatts total. Surface temperature stays below 35 degrees Celsius under all operating conditions.
The thermal problem is solved because the intelligence is solved differently. The display is the thermal load. The AI is not.
HIPAA by architecture, not by agreement
Every clinical AI tool currently deployed requires a Business Associate Agreement. The agreement is supposed to protect patient data. But the data still leaves the clinical environment. It still travels to a server. The risk still exists — it is just contractually acknowledged and partially mitigated.
HAVEN MD does not transmit patient data. It cannot. The clinical knowledge field runs on-device. Voice queries are processed on-device and never transmitted. Clinical notes are stored locally, encrypted at rest. There is no cloud dependency in any part of the architecture that touches patient information.
HIPAA compliance is not achieved by signing an agreement. It is achieved by having no data to breach. That is physics, not policy.
The HAVEN suite in the clinical context
HAVEN MD is most powerful when it operates as part of the full HAVEN ecosystem. A paramedic with HAVEN Ear in their ear, HAVEN Watch on their patient, and HAVEN MD in their hand has a complete, coordinated clinical intelligence system — vitals from the Watch feeding into the MD's knowledge field in real time, Heinrich answers delivered to the Ear hands-free while both hands remain on the patient, all of it offline, all of it at total device power draw under 70 milliwatts across all three devices.
In the operating theatre, HAVEN MD pairs with HAVEN Lens: the handheld device provides the full clinical knowledge context while the glasses provide anatomy overlays in the surgeon's field of view. The query runs on the MD. The answer appears where the surgeon looks.
The HAVEN suite is not a collection of separate products that happen to share a brand. It is a coordinated intelligence architecture where each device's role is defined by what the person wearing it needs their hands, eyes, and ears to be doing.
Who HAVEN MD is for
The 60 million North Americans living in health care deserts — where the nearest specialist is hours away and the local physician has no specialist on call — deserve clinical decision support that does not require an internet connection. The paramedic at a remote accident scene deserves a drug interaction reference that does not require cell signal. The global health worker in a low-resource setting deserves the same knowledge depth as a physician in a major urban hospital.
HAVEN MD is not designed for the best-resourced clinical environments. It is designed for every clinical environment. The ones where the gap between available knowledge and needed knowledge is largest are the ones that matter most.
What comes next
HAVEN MD is in R&D concept phase, with production target Q4 2027. The biological knowledge subfield — targeting 1.5 to 2 million curated clinical nodes — is being built from the same Heinrich staging store that now holds 68 million concepts and continues to grow. Clinical advisor review, regulatory pathway mapping for Health Canada and FDA, and field trial planning in remote medicine contexts follow through 2026 and 2027.
The intelligence is already being built. The device is next.
Engineered for Presence.
Stay in the loop
EMPHOS publishes twice a week — product updates, research, and the thinking behind the build.
Explore Haven · HEINRICH Intelligence · The EMPHOS Vision · All Posts
EMPHOS Group · Chilliwack, BC, Canada · info@emphosgroup.com